Does OSIMERTINIB Cause Metastasis? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Metastasis have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.4% of all adverse event reports for OSIMERTINIB.
113
Reports of Metastasis with OSIMERTINIB
0.4%
of all OSIMERTINIB reports
25
Deaths
24
Hospitalizations
How Dangerous Is Metastasis From OSIMERTINIB?
Of the 113 reports, 25 (22.1%) resulted in death, 24 (21.2%) required hospitalization, and 2 (1.8%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which OSIMERTINIB Alternatives Have Lower Metastasis Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN